Stem cells applications in regenerative medicine and disease therapeutics

RS Mahla - International journal of cell biology, 2016 - Wiley Online Library
Regenerative medicine, the most recent and emerging branch of medical science, deals
with functional restoration of tissues or organs for the patient suffering from severe injuries or …

Stem cells: a promising candidate to treat neurological disorders

CG Song, YZ Zhang, HN Wu, XL Cao… - Neural regeneration …, 2018 - journals.lww.com
Neurologic impairments are usually irreversible as a result of limited regeneration in the
central nervous system. Therefore, based on the regenerative capacity of stem cells …

In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa

B Bakondi, W Lv, B Lu, MK Jones, Y Tsai, KJ Kim… - Molecular Therapy, 2016 - cell.com
Reliable genome editing via Clustered Regularly Interspaced Short Palindromic Repeat
(CRISPR)/Cas9 may provide a means to correct inherited diseases in patients. As proof of …

Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: a pluripotent stem cell-based approach

G Gagliardi, KB M'Barek, O Goureau - Progress in retinal and eye research, 2019 - Elsevier
The human retina fails to regenerate and cell-based therapies offer options for treatment of
blinding retinal diseases, such as macular degeneration and retinitis pigmentosa. The last …

Cell-based therapy for degenerative retinal disease

M Zarbin - Trends in molecular medicine, 2016 - cell.com
Stem cell-derived retinal pigment epithelium (RPE) and photoreceptors (PRs) have restored
vision in preclinical models of human retinal degenerative disease. This review discusses …

Premature ovarian failure and tissue engineering

M Ghahremani‐Nasab, E Ghanbari… - Journal of cellular …, 2020 - Wiley Online Library
Premature ovarian failure (POF) usually happens former to the age of 40 and affects the
female physiological state premenopausal period. In this condition, ovaries stop working …

Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases

MK Jones, B Lu, S Girman, S Wang - Progress in Retinal and Eye Research, 2017 - Elsevier
Cell-based therapeutics offer diverse options for treating retinal degenerative diseases, such
as age-related macular degeneration (AMD) and retinitis pigmentosa (RP). AMD is …

Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model

Y Zhou, S Carmona, A Muhammad… - The Journal of …, 2019 - Am Soc Clin Investig
Mitofusin-2 (MFN2) is a mitochondrial outer-membrane protein that plays a pivotal role in
mitochondrial dynamics in most tissues, yet mutations in MFN2, which cause Charcot-Marie …

[HTML][HTML] Transplantation of human neural stem cells restores cognition in an immunodeficient rodent model of traumatic brain injury

DL Haus, L López-Velázquez, EM Gold… - Experimental …, 2016 - Elsevier
Traumatic brain injury (TBI) in humans can result in permanent tissue damage and has been
linked to cognitive impairment that lasts years beyond the initial insult. Clinically effective …

Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration

AH Laperle, VA Moser, P Avalos, B Lu, A Wu, A Fulton… - Stem Cell Reports, 2023 - cell.com
Human induced pluripotent stem cells (iPSCs) are a renewable cell source that can be
differentiated into neural progenitor cells (iNPCs) and transduced with glial cell line-derived …